Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Multiconsult – investing for growth

Published

on

multiconsult-–-investing-for-growth

OSLO, Norway, Nov. 1, 2023 /PRNewswire/ —

Multiconsult ASA (OSE: MULTI)

The robust organic revenue growth observed throughout 2023 has continued in the third quarter and is 8.4 per cent. Increased activity throughout the quarter resulted in a growth in net operating revenues of 11.5 per cent to NOK 977.0 million. A solid order intake has resulted in a robust and diversified order backlog going forward. In the comparable quarter last year, the result was impacted by an income recognition from an insurance settlement of NOK 13.6 million. Multiconsult’s third quarter EBITA amounted to NOK 29.2 million, which gives an EBITA for the first nine months of 2023 of NOK 301.1 million. The EBITA margin for the quarter was 3.0 per cent, and 8.8 per cent year to date. The billing ratio came in at 67.8 per cent, influenced by investment in the onboarding and training of new hires and recent graduates.   

THIRD QUARTER 2023

  • A quarter with a significant increase employees and overall strong growth
  • Net operating revenues increased to NOK 977.0 million (876.0), a y-o-y growth of 11.5 per cent. The organic revenue growth for the quarter was 8.4 per cent
  • EBITA of NOK 29.2 million (67.8), equal to an EBITA margin of 3.0 per cent (7.7)         
    • In the comparable quarter last year, there was an income recognition of NOK 13.6 million from an insurance settlement
    • Net operating revenues and EBITA impacted negatively by NOK 16.6 million from the calendar effect compared with Q3 2022
  • Other operating expenses of NOK 137.4 million (121.6)      
    • Other opex ratio (ex. IFRS 16) of 19.2 per cent (19.0)
  • Strong order intake of NOK 1 349 million (945)
  • Billing ratio of 67.8 per cent (68.3), down 0.5pp
  • Full-time equivalents (FTE) increased by 8.7 per cent, to 3 469 (3 191)
  • Market outlook for Multiconsult’s services is still good, but has levelled off

YEAR TO DATE 2023

  • Net operating revenues of NOK 3 441.0 million (3 062.6), a y-o-y growth of 12.4 per cent. The organic revenue growth for the period was 11.6 per cent
  • EBITA of NOK 301.1 million (311.7), equal to an EBITA margin of 8.8 per cent (10.2)
  • Order intake at a high level of NOK 5 495 million (3 636)
  • All-time high order backlog of NOK 5 094 million (3 424)
  • Other operating expenses of NOK 428.0 million (380.9)      
    • Other opex ratio (ex. IFRS 16) of 16.7 per cent (16.9)
  • Net profit of NOK 203.7 million (227.4)
  • Earnings per share 7.46 (8.30)
  • Full-time equivalents (FTE) increased by 6.9 per cent, to 3 340 (3 125)

CO-OWNERSHIP AMONG EMPLOYEES

To encourage even more of our employees to seize the opportunity to become co-owners in Multiconsult we are excited to announce that in connection with this year’s share programme we will also offer a limited number of complimentary shares, to all our valued employees. All employees will be given the opportunity to receive 40 complimentary shares in Multiconsult (MULTI) regardless of previous ownership or participation in this years program. In addition, we will enhance communication and training about the annual share programme. This offers an excellent opportunity for all employees to participate in the value creation they so strongly contribute to.

COMMENTS FROM CEO, GRETHE BERGLY:

“In the third quarter Multiconsult delivered a quarter with strong growth, and the demand for our services still remains robust, as evidenced by strong sales and a record high order backlog. I am grateful to our skilled and dedicated employees for their contribution, and this quarter would like to extend a warm welcome to all new team members, whether it is in Iterio, LINK Arkitektur, A-lab, Multiconsult Polska or Multiconsult Norge.  The increase in net operating revenues is mainly driven by increased capacity and higher billing rates, and the underlying organic growth is strong. The EBITA for the quarter amounted to NOK 29.2 million and is affected by one less calendar day compared to third quarter last year, reflecting an EBITA margin of 3.0 per cent (8.8 per cent YTD). The result in the quarter is impacted by a significant increase in number of employees and an unsatisfactory low billing ratio.

We can look back at another quarter with strong organic growth, continuing the momentum we have maintained so far in 2023. Despite strong sales and an all-time high order backlog, the quarter is characterised by an unsatisfactory low billing ratio of 67.8 per cent. During the quarter we welcomed 225 new employees to the Multiconsult group confirming our standing as a preferred employer and our commitment to invest in the future and organic growth. Among our new employees a large number are recent graduates. The onboarding and training of new hires and in particular recent graduates affects the billing ratio in the short term. The investment in graduates is paramount for further growth and future value creation. Our all-time high order backlog and sales positions us well to win projects in areas of growth and maintain our strong market position.

We see the value in co-ownership among employees through many positive aspects for all stakeholders and we strongly believe that co-ownership strengthens the ties between employees and the affiliation to the company as it increases the general interest in the company’s total financial results, growth, and operational performance.

We still experience great demand for our services, even though the market situation varies geographically and between our business areas. We are pleased to report solid order intake during the quarter and further strengthening of our robust and diversified order backlog to NOK 5.1 billion, an increase of 3.1 per cent from the second quarter and 48.8 per cent compared to the end of third quarter last year. Entering a more demanding and mixed marked situation we are mobilising the organisation to ensure a high level of alertness in our marked activities and preparedness for necessary changes to maintain our level of value creation. Where the demand within markets like transportation, energy and industry, as well as energy efficiency, remains strong, some parts of the building and property sectors have slowed down. The strength of our flexible business model allows us to shift resources to areas of growth, positions us well to win projects in these growing markets while maintaining our position in stable markets.”

For a full review of comments from our CEO, please refer third quarter result 2023 report.

FINANCIAL REVIEW, THIRD QUARTER 2023:

Net operating revenues amounted to NOK 977.0 million (876.0), an increase of 11.5 per cent compared to the same quarter last year. The organic revenue growth amounted to 8.4 per cent adjusted for calendar effect and acquisition. The increase in net operating revenues was mainly driven by higher capacity, reflected by an increase in full-time equivalents (FTE) by 8.7 per cent. Additionally, higher billing rates made positive contribution to the growth in net operating revenues. The growth in net operating revenues was offset by lower billing ratio of 0.5pp, which came in at 67.8 per cent (68.3). In the comparable quarter last year net operating revenues was impacted by an income recognition from an insurance settlement of NOK 13.6 million.

Operating expenses consist of employee benefit expenses and other operating expenses. Operating expenses increased by 17.5 per cent to NOK 889.8 million (757.3) compared to the same quarter in 2022. Employee benefit expenses increased by 18.3 per cent due to ordinary salary adjustment, increased manning level from acquisitions and significant increase in net recruitment. Other operating expenses increased to NOK 137.4 million (121.6), an increase of 13.0 per cent mainly due to higher office expenditure including office expenses from acquired companies, cost related to a higher manning level, IT-cost and cost increase in general.

EBITDA was NOK 87.2 million (118.7), a decrease of 26.5 per cent compared to the same period last year, reflecting an EBITDA margin of 8.9 per cent (13.5) in the quarter.

EBITA was NOK 29.2 million (67.8), reflecting an EBITA margin of 3.0 per cent (7.7) in the quarter.

Calendar effect. In the third quarter of 2023 there was one less working day compared to the third quarter 2022. This had an estimated negative impact of NOK 16.6 million on net operating revenues and on operating results for the group when comparing the figures.

FINANCIAL REVIEW, YEAR TO DATE 2023:

Net operating revenues increased by 12.4 per cent to NOK 3 441.0 million (3 062.6), when compared to the same period last year. The organic revenue growth amounted to 10.7 per cent adjusted for calendar effect and acquisition. The increase in net operating revenues was mainly driven by higher capacity, reflected by an increase in full-time equivalents (FTE) of by 6.7 per cent and higher billing rates. The growth in net operating revenues was offset by lower billing ratio which came in at 70.4 per cent (70.7)

Operating expenses consist of employee benefit expenses and other operating expenses. Operating expenses increased by 14.4 per cent to NOK 2 973.3 million (2 598.8) compared to the same period last year. Employee benefit expenses increased by 14.8 per cent and amounted to NOK 2 545.3 million (2 217.9), an increase mainly driven by ordinary salary adjustment, increased manning level from acquisitions and net recruitment. Other operating expenses increased by 12.3 per cent to NOK 428.0 million (380.9), mainly due to higher office expenditure including office expenses from acquired companies, cost related to a higher manning level, IT-cost and cost increase in general.

EBITDA was NOK 467.7 million (463.8), a decrease of 0.8 per cent compared to the same period last year, reflecting an EBITDA margin of 13.6 per cent (15.1).

EBITA was NOK 301.1 million (311.7), a decrease of 11.5 per cent y-o-y, reflecting an EBITA margin of 8.8 per cent (10.2).Net operating revenues increased by 12.7 per cent to NOK 2 464.0 million (2 186.6), when compared to the same period last year. The billing rates continued to improve and contributed positively on net operating revenues. Billing ratio came in at 71.5 per cent down 0.1pp. Organic growth in the period was 11.6 per cent, adjusted for calendar effect and acquisition.

OUTLOOK

The market outlook for Multiconsult’s services is still good but has levelled off. Despite this uncertainty, the market outlook remains favourable. There are substantial differences in the market outlook when it comes to certain geographical areas and our business areas, and Multiconsult mobilise to navigate in a more complex environment. The short term pipeline of upcoming projects remains robust, although there is a slight reduction in general market opportunities. Lower investment levels in certain markets are expected to intensify competition and margin pressures. Nevertheless, with a high volume of ongoing projects, a diverse portfolio and a high order backlog, Multiconsult is well-positioned for the future.

For a full review of outlook and report, please refer to our third quarter result 2023 report.

Presentations today 1 November 2023:

Participants are invited to attend the presentations that will be held at our main office: Nedre Skøyen vei 2, Oslo, Norway at 08:30 CET.

The results and the Extended Quarter Presentation will also be presented through a live webcast and be accessed at

https://channel.royalcast.com/landingpage/hegnarmedia/20231101_1/ or through link found at Multiconsult Investor Relation website.

Live webcasts, complete report, presentation and a recording of the webcast will be available on www.multiconsult-ir.com and https://newsweb.oslobors.no/

For further information, please contact:

   Investor relations:

      Ove B. Haupberg, CFO

      Phone: +47 401 00 900

      E-mail: [email protected]  

   Media:    

      Gaute Christensen, VP Communications

      Phone: +47 911 70 188

      E-mail: [email protected]  

The following files are available for download:

 

  

View original content:https://www.prnewswire.co.uk/news-releases/multiconsult–investing-for-growth-301973787.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending